{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T15:36:37Z","timestamp":1777736197521,"version":"3.51.4"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:00:00Z","timestamp":1756771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:00:00Z","timestamp":1756771200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Guangxi Zhuang Autonomous Region Health Commission Key Laboratory of Medical Genetics and Genomics Research Open Project","award":["GXKMGG202304"],"award-info":[{"award-number":["GXKMGG202304"]}]},{"name":"Guangxi Zhuang Autonomous Region Health Commission self-funded scientific research projects","award":["Z-A20240639"],"award-info":[{"award-number":["Z-A20240639"]}]},{"name":"the Guangxi natural science foundation of China","award":["2023JJA140185"],"award-info":[{"award-number":["2023JJA140185"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-03368-4","type":"journal-article","created":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:01:42Z","timestamp":1756771302000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Upregulation of EMP3 in acute myeloid leukemia: a study based on data mining, RT-qPCR and immunohistochemistry"],"prefix":"10.1007","volume":"16","author":[{"given":"Angui","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianwei","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaodi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yubing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanglai","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinghui","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,2]]},"reference":[{"issue":"21","key":"3368_CR1","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1182\/blood.2024025409","volume":"144","author":"H Dohner","year":"2024","unstructured":"Dohner H, DiNardo CD, Appelbaum FR, Craddock C, Dombret H, Ebert BL, Fenaux P, Godley LA, Hasserjian RP, Larson RA, et al. Genetic risk classification for adults with AML receiving less-intensive therapies: the 2024 ELN recommendations. Blood. 2024;144(21):2169\u201373.","journal-title":"Blood"},{"issue":"12","key":"3368_CR2","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1182\/blood.2022016867","volume":"140","author":"H Dohner","year":"2022","unstructured":"Dohner H, Wei AH, Appelbaum FR, Craddock C, DiNardo CD, Dombret H, Ebert BL, Fenaux P, Godley LA, Hasserjian RP, et al. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood. 2022;140(12):1345\u201377.","journal-title":"Blood"},{"issue":"23","key":"3368_CR3","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1056\/NEJMoa1516192","volume":"374","author":"E Papaemmanuil","year":"2016","unstructured":"Papaemmanuil E, Gerstung M, Bullinger L, Gaidzik VI, Paschka P, Roberts ND, Potter NE, Heuser M, Thol F, Bolli N, et al. Genomic classification and prognosis in acute myeloid leukemia. N Engl J Med. 2016;374(23):2209\u201321.","journal-title":"N Engl J Med"},{"issue":"2","key":"3368_CR4","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1159\/000536152","volume":"147","author":"F Wachter","year":"2024","unstructured":"Wachter F, Pikman Y. Pathophysiology of acute myeloid leukemia. Acta Haematol. 2024;147(2):229\u201346.","journal-title":"Acta Haematol"},{"issue":"3\u20134","key":"3368_CR5","doi-asserted-by":"publisher","first-page":"227","DOI":"10.3233\/CBM-230504","volume":"40","author":"W Zhu","year":"2024","unstructured":"Zhu W, Song S, Xu Y, Sheng H, Wang S. EMP3: a promising biomarker for tumor prognosis and targeted cancer therapy. Cancer Biomark. 2024;40(3\u20134):227\u201339.","journal-title":"Cancer Biomark"},{"issue":"1","key":"3368_CR6","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12885-023-11796-0","volume":"24","author":"L Li","year":"2024","unstructured":"Li L, Xia S, Zhao Z, Deng L, Wang H, Yang D, Hu Y, Ji J, Huang D, Xin T. EMP3 as a prognostic biomarker correlates with EMT in GBM. BMC Cancer. 2024;24(1):89.","journal-title":"BMC Cancer"},{"issue":"11","key":"3368_CR7","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.52586\/5018","volume":"26","author":"Q Lv","year":"2021","unstructured":"Lv Q, Xiao W, Xiong Z, Shi J, Miao D, Meng X, Yuan H, Yang H, Zhang X. Identification of candidate biomarker EMP3 and its prognostic potential in clear cell renal cell carcinoma. Front Biosci (Landmark Ed). 2021;26(11):1176\u201390.","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"Database issue","key":"3368_CR8","first-page":"D991","volume":"41","author":"T Barrett","year":"2013","unstructured":"Barrett T, Wilhite SE, Ledoux P, Evangelista C, Kim IF, Tomashevsky M, Marshall KA, Phillippy KH, Sherman PM, Holko M, et al. NCBI GEO: archive for functional genomics data sets\u2013update. Nucleic Acids Res. 2013;41(Database issue):D991\u2013995.","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"3368_CR9","doi-asserted-by":"publisher","first-page":"4539","DOI":"10.1007\/s10238-023-01131-z","volume":"23","author":"DG Gupta","year":"2023","unstructured":"Gupta DG, Varma N, Abdulkadir SA, Singh P, Sachdeva MUS, Naseem S, Siddiqui MR, Bose P, Binota J, Malhotra P, Khadwal A, Varma S. Identification and validation of the optimal reference genes for standardizing the gene expression profiling diagnostic panel of Ph-like B-lineage acute lymphoblastic leukemia. Clin Exp Med. 2023;23(8):4539\u201351.","journal-title":"Clin Exp Med"},{"issue":"6","key":"3368_CR10","doi-asserted-by":"publisher","first-page":"4841","DOI":"10.1007\/s11033-022-07337-w","volume":"49","author":"DG Gupta","year":"2022","unstructured":"Gupta DG, Varma N, Kumar A, Naseem S, Sachdeva MUS, Bose P, Binota J, Gupta M, Sonam P, Rana P, Malhotra P, Varma S. Identification and validation of suitable housekeeping genes for gene expression studies in BCR-ABL1 positive B-lineage acute lymphoblastic leukemia. Mol Biol Rep. 2022;49(6):4841\u20138.","journal-title":"Mol Biol Rep"},{"issue":"1","key":"3368_CR11","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41416-023-02294-y","volume":"129","author":"DG Gupta","year":"2023","unstructured":"Gupta DG, Varma N, Sreedharanunni S, Abdulkadir SA, Naseem S, Sachdeva MUS, Binota J, Bose P, Malhotra P, Khadwal A, Varma S. Evaluation of adverse prognostic gene alterations & MRD positivity in BCR::ABL1-like B-lineage acute lymphoblastic leukaemia patients, in a resource-constrained setting. Br J Cancer. 2023;129(1):143\u201352.","journal-title":"Br J Cancer"},{"issue":"33","key":"3368_CR12","doi-asserted-by":"publisher","first-page":"20117","DOI":"10.1073\/pnas.2003900117","volume":"117","author":"L Jiang","year":"2020","unstructured":"Jiang L, Li XP, Dai YT, Chen B, Weng XQ, Xiong SM, Zhang M, Huang JY, Chen Z, Chen SJ. Multidimensional study of the heterogeneity of leukemia cells in t(8;21) acute myelogenous leukemia identifies the subtype with poor outcome. Proc Natl Acad Sci U S A. 2020;117(33):20117\u201326.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"3368_CR13","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1007\/s11684-021-0836-7","volume":"15","author":"X Li","year":"2021","unstructured":"Li X, Dai Y, Chen B, Huang J, Chen S, Jiang L. Clinical significance of CD34(+)CD117(dim)\/CD34(+)CD117(bri) myeloblast-associated gene expression in t(8;21) acute myeloid leukemia. Front Med. 2021;15(4):608\u201320.","journal-title":"Front Med"},{"issue":"9","key":"3368_CR14","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/s41419-021-04140-6","volume":"12","author":"K Zhou","year":"2021","unstructured":"Zhou K, Sun Y, Dong D, Zhao C, Wang W. EMP3 negatively modulates breast cancer cell DNA replication, DNA damage repair, and stem-like properties. Cell Death Dis. 2021;12(9):844.","journal-title":"Cell Death Dis"},{"issue":"1","key":"3368_CR15","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s40478-023-01673-z","volume":"11","author":"AA Martija","year":"2023","unstructured":"Martija AA, Krauss A, Bachle N, Doth L, Christians A, Krunic D, Schneider M, Helm D, Will R, Hartmann C, et al. EMP3 sustains oncogenic EGFR\/CDK2 signaling by restricting receptor degradation in glioblastoma. Acta Neuropathol Commun. 2023;11(1):177.","journal-title":"Acta Neuropathol Commun"},{"key":"3368_CR16","doi-asserted-by":"publisher","first-page":"216398","DOI":"10.1016\/j.canlet.2023.216398","volume":"575","author":"Q Ma","year":"2023","unstructured":"Ma Q, Zhang Y, Liang H, Zhang F, Liu F, Chen S, Hu Y, Jiang L, Hao Y, Li M, et al. EMP3 as a key downstream target of miR-663a regulation interferes with MAPK\/ERK signaling pathway to inhibit gallbladder cancer progression. Cancer Lett. 2023;575:216398.","journal-title":"Cancer Lett"},{"issue":"1","key":"3368_CR17","doi-asserted-by":"publisher","first-page":"80","DOI":"10.18632\/aging.102598","volume":"12","author":"Q Guo","year":"2019","unstructured":"Guo Q, Jing FJ, Xu W, Li X, Li X, Sun JL, Xing XM, Zhou CK, Jing FB. Ubenimex induces autophagy Inhibition and EMT suppression to overcome cisplatin resistance in GC cells by perturbing the CD. Aging. 2019;12(1):80\u2013105. 13\/EMP3\/PI3K\/AKT\/NF-kappaB axis.","journal-title":"Aging"},{"issue":"7","key":"3368_CR18","doi-asserted-by":"publisher","first-page":"101042831771840","DOI":"10.1177\/1010428317718404","volume":"39","author":"M Han","year":"2017","unstructured":"Han M, Xu W. EMP3 is induced by TWIST1\/2 and regulates epithelial-to-mesenchymal transition of gastric cancer cells. Tumour Biol. 2017;39(7):1010428317718404.","journal-title":"Tumour Biol"},{"key":"3368_CR19","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.cellimm.2017.12.001","volume":"324","author":"Y Kusumoto","year":"2018","unstructured":"Kusumoto Y, Okuyama H, Shibata T, Konno K, Takemoto Y, Maekawa D, Kononaga T, Ishii T, Akashi-Takamura S, Saitoh SI, et al. Epithelial membrane protein 3 (Emp3) downregulates induction and function of cytotoxic T lymphocytes by macrophages via TNF-alpha production. Cell Immunol. 2018;324:33\u201341.","journal-title":"Cell Immunol"},{"issue":"1","key":"3368_CR20","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s13046-021-01954-2","volume":"40","author":"Q Chen","year":"2021","unstructured":"Chen Q, Jin J, Huang X, Wu F, Huang H, Zhan R. EMP3 mediates glioblastoma-associated macrophage infiltration to drive T cell exclusion. J Exp Clin Cancer Res. 2021;40(1):160.","journal-title":"J Exp Clin Cancer Res"},{"issue":"18","key":"3368_CR21","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1182\/blood.2023020211","volume":"142","author":"S Decombis","year":"2023","unstructured":"Decombis S, Bellanger C, Le Bris Y, Madiot C, Jardine J, Santos JC, Boulet D, Dousset C, Menard A, Kervoelen C, et al. CARD11 gain of function upregulates BCL2A1 expression and promotes resistance to targeted therapies combination in B-cell lymphoma. Blood. 2023;142(18):1543\u201355.","journal-title":"Blood"},{"key":"3368_CR22","doi-asserted-by":"crossref","unstructured":"Burley TA, Kennedy E, Broad G, Boyd M, Li D, Woo T, West C, Ladikou EE, Ashworth I, Fegan C et al. Targeting the Non-Canonical NF-kappaB pathway in chronic lymphocytic leukemia and multiple myeloma. Cancers (Basel) 2022;14(6).","DOI":"10.3390\/cancers14061489"},{"issue":"8","key":"3368_CR23","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1038\/s43018-020-0103-x","volume":"1","author":"H Zhang","year":"2020","unstructured":"Zhang H, Nakauchi Y, Kohnke T, Stafford M, Bottomly D, Thomas R, Wilmot B, McWeeney SK, Majeti R, Tyner JW. Integrated analysis of patient samples identifies biomarkers for venetoclax efficacy and combination strategies in acute myeloid leukemia. Nat Cancer. 2020;1(8):826\u201339.","journal-title":"Nat Cancer"},{"issue":"2","key":"3368_CR24","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1111\/ijlh.14410","volume":"47","author":"H Alharbi","year":"2025","unstructured":"Alharbi H, Ahmad M, Cui Z, Meng D, Xin Y, Yan X. Identification of potential biomarkers and pathways in acute myeloid leukemia: correlation between the calcineurin signaling pathway and vascular brittleness in acute myeloid leukemia. Int J Lab Hematol. 2025;47(2):288\u201396.","journal-title":"Int J Lab Hematol"},{"key":"3368_CR25","doi-asserted-by":"publisher","first-page":"101354","DOI":"10.1016\/j.tranon.2022.101354","volume":"18","author":"K Yamatani","year":"2022","unstructured":"Yamatani K, Ai T, Saito K, Suzuki K, Hori A, Kinjo S, Ikeo K, Ruvolo V, Zhang W, Mak PY, et al. Inhibition of BCL2A1 by STAT5 inactivation overcomes resistance to targeted therapies of FLT3-ITD\/D835 mutant AML. Transl Oncol. 2022;18:101354.","journal-title":"Transl Oncol"},{"issue":"6","key":"3368_CR26","doi-asserted-by":"publisher","first-page":"3062","DOI":"10.21037\/tcr-24-810","volume":"13","author":"C Zhou","year":"2024","unstructured":"Zhou C, Yang L, Zhao K, Jiang L. ITGAM sustains MAPK signaling and serves as an adverse prognostic factor and therapeutic target in acute myeloid leukemia. Transl Cancer Res. 2024;13(6):3062\u201374.","journal-title":"Transl Cancer Res"},{"issue":"12","key":"3368_CR27","doi-asserted-by":"publisher","first-page":"16445","DOI":"10.18632\/aging.203166","volume":"13","author":"J Wang","year":"2021","unstructured":"Wang J, Hao JP, Uddin MN, Wu Y, Chen R, Li DF, Xiong DQ, Ding N, Yang JH, Ding XS. Identification and validation of inferior prognostic genes associated with immune signatures and chemotherapy outcome in acute myeloid leukemia. Aging. 2021;13(12):16445\u201370.","journal-title":"Aging"},{"issue":"8","key":"3368_CR28","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1038\/s41375-023-01953-6","volume":"37","author":"S Hou","year":"2023","unstructured":"Hou S, Wang X, Guo T, Lan Y, Yuan S, Yang S, Zhao F, Fang A, Liu N, Yang W, et al. PHF6 maintains acute myeloid leukemia via regulating NF-kappaB signaling pathway. Leukemia. 2023;37(8):1626\u201337.","journal-title":"Leukemia"},{"issue":"4","key":"3368_CR29","doi-asserted-by":"publisher","first-page":"520","DOI":"10.7150\/ijms.80047","volume":"20","author":"X Shao","year":"2023","unstructured":"Shao X, Zhong L, Chu X, Wan P, Chen S, Zhou Z, Zhang H, Wang M, Liu B. ZNF460-regulated COMMD7 promotes acute myeloid leukemia proliferation via the NF-kappaB signaling pathway. Int J Med Sci. 2023;20(4):520\u20139.","journal-title":"Int J Med Sci"},{"issue":"1","key":"3368_CR30","doi-asserted-by":"publisher","first-page":"11444","DOI":"10.1038\/s41598-022-15020-0","volume":"12","author":"F Wang","year":"2022","unstructured":"Wang F, Yang L, Xiao M, Zhang Z, Shen J, Anuchapreeda S, Tima S, Chiampanichayakul S, Xiao Z. PD-L1 regulates cell proliferation and apoptosis in acute myeloid leukemia by activating PI3K-AKT signaling pathway. Sci Rep. 2022;12(1):11444.","journal-title":"Sci Rep"},{"issue":"4","key":"3368_CR31","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s11912-023-01389-2","volume":"25","author":"R Bystrom","year":"2023","unstructured":"Bystrom R, Levis MJ. An update on FLT3 in acute myeloid leukemia: pathophysiology and therapeutic landscape. Curr Oncol Rep. 2023;25(4):369\u201378.","journal-title":"Curr Oncol Rep"},{"issue":"1","key":"3368_CR32","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1182\/bloodadvances.2019000709","volume":"4","author":"Y Ishikawa","year":"2020","unstructured":"Ishikawa Y, Kawashima N, Atsuta Y, Sugiura I, Sawa M, Dobashi N, Yokoyama H, Doki N, Tomita A, Kiguchi T, et al. Prospective evaluation of prognostic impact of KIT mutations on acute myeloid leukemia with RUNX1-RUNX1T1 and CBFB-MYH11. Blood Adv. 2020;4(1):66\u201375.","journal-title":"Blood Adv"},{"issue":"5","key":"3368_CR33","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1080\/10428194.2023.2190432","volume":"64","author":"MK Mustafa Ali","year":"2023","unstructured":"Mustafa Ali MK, Williams MT, Corley EM, AlKaabba F, Niyongere S. Impact of KRAS and NRAS mutations on outcomes in acute myeloid leukemia. Leuk Lymphoma. 2023;64(5):962\u201371.","journal-title":"Leuk Lymphoma"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03368-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-03368-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03368-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T01:56:47Z","timestamp":1757469407000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-03368-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,2]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3368"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-03368-4","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,2]]},"assertion":[{"value":"13 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research program was approved by the Medical Ethics Committee of the Second Affiliated Hospital of Guangxi Medical University(Approval Number:2025-KY0255). All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional. All participants signed informed consent forms.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1668"}}